Details about the neuroanatomical projections from ORBvl to RSPv-a
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure |
Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|
| 91812 |
Orbital area ventrolateral part | Retrosplenial area ventral part zone a |
light | biotinylated dextran amine (BDA) | Collator note: terminals and fibers in the caudal RSPv-a, close to the border with the POST. See Fig. 10B, Swanson Atlas Levels 39-40. | Kondo H. & Witter M.P., 2014 |
|---|
| 91816 |
Orbital area ventrolateral part | Retrosplenial area ventral part zone a |
light/moderate | biotinylated dextran amine (BDA) | Collator note: the terminal field in POST extends for a very small distance in the ventral RSPV-a, in the superficial layers. See Fig. 10B, Swanson Atlas Levels 42-43. | Kondo H. & Witter M.P., 2014 |
|---|
|
General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Further details associated to record number 91816:
| Position of injection: caudo-lateral |
| Topological position of injection: is contained |
| Extension of injection outside: none |
| The injection was performed in: left hemisphere |
| | Position of terminal field: caudo-ventral |
| Topological position of terminal field: is contained |
| Extension of terminal field outside: none |
| The terminal field was found: ipsilateral |
| |
